Univariate and multivariate analyses revealed that MCM2, MCM4, MCM6, MCM7 expression and tumor grade, 1p/19q codeletion, primary therapy outcome, and age were independent factors correlated with poor clinical outcomes of glioma patients. The gene discussed is MCM4; the disease is central nervous system cancer.